Yea, agree. We've heard every quarter about the dollar strength and local currency weakness. There are business ways to adjust for this, instead of the quarterly blame-game. It can't continue to the excuse du-jour (du-trimestre or du-an).
I continue to think a lot of money was recently squandered on all these acquisitions they used their cash for, let alone doing a bond-offering for the "potential" that also was vaporware. The HIV licensing stuff too, I scratch my head.
Yup, a lot is riding on the triponin offering(s). Way too much, IMHO.